Literature DB >> 19380032

Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.

Gulsun Erdag1, Jeanne M Meck, Aurelia Meloni-Ehrig, Ludmila Matyakhina, Theresa Donohue, Ramaprasad Srinivasan, Philip Mowrey, JoAnn Kelly, Aleah Smith, Richard Childs.   

Abstract

We describe the cases of two unrelated patients who exhibited multiple chromosomal abnormalities in donor cells after allogeneic peripheral blood stem cell transplantation (PBSCT). The patients were diagnosed with chronic myeloid leukemia and chronic lymphocytic leukemia, respectively, and both underwent nonmyeloablative conditioning with cyclophosphamide and fludarabine followed by PBSCT from their HLA-matched opposite-sex siblings. Post-transplant bone marrow cytogenetics showed full engraftment, and the early post-transplant studies demonstrated only normal donor metaphases. Subsequent studies of both patients, however, revealed a population of metaphase cells with abnormal, but apparently balanced, donor karyotypes. Chromosome studies performed on peripheral blood cells collected from both donors after transplantation were normal. Both patients remained in clinical remission during follow-up of approximately 8 years in one case, and 6 years in the other case, despite the persistence of the abnormal clones. Chromosomal abnormalities in residual recipient cells after bone marrow or PBSCT are not unusual. In contrast, only rare reports of chromosome abnormalities in donor cells exist, all of which have been associated with post-bone marrow transplant myelodysplastic syndrome or acute leukemias. The present cases demonstrate the rare phenomenon of persistent clonal nonpathogenic chromosome aberrations in cells of donor origin.

Entities:  

Mesh:

Year:  2009        PMID: 19380032      PMCID: PMC2764294          DOI: 10.1016/j.cancergencyto.2009.01.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  28 in total

Review 1.  Chromosomal translocation t(14;18) in healthy individuals.

Authors:  Frank Schüler; Carsten Hirt; Gottfried Dölken
Journal:  Semin Cancer Biol       Date:  2003-06       Impact factor: 15.707

Review 2.  Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.

Authors:  M Lawler; A Locasciulli; D Longoni; R Schiro; S R McCann
Journal:  Bone Marrow Transplant       Date:  2002-03       Impact factor: 5.483

3.  Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation.

Authors:  Bruno C Medeiros; Kathy Chun; Suzanne Kamel-Reid; Jeffrey Lipton
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

Review 4.  Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.

Authors:  L D Cooley; D A Sears; M M Udden; W R Harrison; K R Baker
Journal:  Am J Hematol       Date:  2000-01       Impact factor: 10.047

Review 5.  Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.

Authors:  Marc Loriaux; Michael Deininger
Journal:  Leuk Lymphoma       Date:  2004-11

6.  Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

Authors:  Vicki A Morrison; Kanti R Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Richard A Larson; Charles A Schiffer
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

7.  Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.

Authors:  Hermine Agis; Christine Mannhalter; Wolfgang R Sperr; Felix Keil; Peter Kalhs; Hendrati Pirc-Danoewinata; Maria-Theresa Krauth; Oskar A Haas; Klaus Geissler; Klaus Lechner; Peter Valent
Journal:  Leuk Lymphoma       Date:  2004-07

8.  Chromosomal transformation in donor cells following allogeneic bone marrow transplantation.

Authors:  Z Lang; P Dinndorf; S Ladisch; E Bayever; G Reaman
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

Review 9.  Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment.

Authors:  Deborah Rund; Dina Ben-Yehuda
Journal:  Hematology       Date:  2004-06       Impact factor: 2.269

10.  Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia.

Authors:  Irén Haltrich; Judit Müller; Judit Szabó; Gábor Kovács; Rozália Kóos; Anna Poros; Matild Dobos; György Fekete
Journal:  Cancer Genet Cytogenet       Date:  2003-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.